Product Safety Recalls

Product Recall Tracker

Recall D-0130-2023

Description: Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1

Recall D-0130-2023 Information

Mandated?Voluntary: Firm initiated
Recall NumberD-0130-2023
Event ID91378
DistributionNationwide to medical facilities.
Quantity11,453 vials
Recall ReasonCGMP Deviations: Raw material recalled by repackager, due to discoloration.
Drug ClassificationClass II
Drug Code Info20230111
Recall Initiation Date20221222
Report Date20230111
Classification Date20230113
Address355 Riverwalk Pkwy
Tonawanda, NY 14150-5837
United States
Recalling FirmPine Pharmaceuticals, LLC
Initial Notification E-Mail
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.